Michael Lindner, MD
Gastroenterology · Bozeman, MTNPI 1649274309
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,991 of the $4,251 with a category attached, or 70.4%. 22 manufacturers reported payments, led by Boston Scientific at 47.0% of the total. Reporting peaked in 2023 at $1,610 and has fallen 58.6% since, to $667 in 2025. Among gastroenterology clinicians in MT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 116 payments — averaging $36.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- AbbVie$778
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$227
- Takeda Pharmaceuticals U.S.A., Inc.$222
- Johnson & Johnson$167
- Olympus America Inc.$160
- plus $699 from 16 others
What the payments were for
- Travel & lodging$1,25930%
- Food & beverage$2,99170%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 12 | $1,999 |
| AbbVie(2 entities) | 19 | $778 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 15 | $227 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $222 |
| Johnson & Johnson(2 entities) | 14 | $167 |
| Olympus America Inc. | 3 | $160 |
| Ardelyx, Inc. | 1 | $136 |
| Ferring Pharmaceuticals Inc. | 8 | $102 |
| Redhill Biopharma Inc. | 7 | $93 |
| Pfizer | 6 | $92 |
| Shionogi Inc | 3 | $55 |
| Bristol Myers Squibb | 3 | $43 |
| Micro-tech Endoscopy USA, Inc. | 3 | $31 |
| Merck | 2 | $31 |
| Intercept Pharmaceuticals, Inc. | 1 | $21 |
| Braintree Laboratories, Inc. | 1 | $17 |
| Nestle Healthcare Nutrition Inc. | 1 | $16 |
| Gilead | 1 | $14 |
| Amgen | 1 | $14 |
| Alfasigma USA, Inc. | 1 | $12 |
| AstraZeneca | 1 | $11 |
| QOL Medical, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EXALT Model D$1,449
- Skyrizi$396
- DISPOSABLE BIOPSY FORCEPS$144
- IBSRELA$136
- Rinvoq$111
How this compares
$4,251 in reported general payments places this provider in the 90th percentile of 34 gastroenterology providers in Montana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 33 | $17,748 |
| Lubiprostone | 11 | $1,858 |
| Dexlansoprazole DrDexlansoprazole | 11 | $1,673 |
| Omeprazole | 113 | $1,037 |
| Pantoprazole Sodium | 52 | $793 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 11 | $638 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 32 | $564 |
| Rabeprazole Sodium | 22 | $555 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 31 | $511 |
| Dicyclomine Hcl | 32 | $448 |
| Metoclopramide Hcl | 19 | $179 |
| Baclofen | 13 | $98 |
| Famotidine | 14 | $95 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess | $778 | $17,74833 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 34 gastroenterology providers in Montana.
Other gastroenterology in Bozeman
- Andrew HermanBozeman$7K
- Waring TribleBozeman$5K
- Andrew GentryBozeman$3K
- Kathryn LynchBozeman$3K
- Peter WalshBozeman$2K
- Nathaniel Spezia-LindnerBozeman$336
- Brian LandsverkBozeman$111
- Steven ShaneyfeltBozeman$38
- Juergen MuellerKalispell$4K
- Scott CooperMissoula$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.